Patent ID: 8613916
Filing Date: 2013-12-24
Classification: A61K,A61P,C12N

Abstract:
1. An immunotherapy for pancreatic cancer, which comprises the steps of: culturing peripheral blood lymphocytes of a patient with pancreatic cancer by stimulating the lymphocytes with an anti-CD3 antibody and an anti-CD52 antibody, thereby to obtain an immunotherapeutic agent, and administering at least four infusions of the immunotherapeutic agent to the same patient, wherein each of the infusions of the immunotherapeutic agent comprise at least 15×10 (a) the number of peripheral blood lymphocytes being less than 1,000 cells/μl; (b) the number of CD3 (c) the cytotoxic activity of CD3 (d) the number of NKG2D